Compared with AD-OSA-M group, AD-OSA-MS group had a higher body mass index, lower scores of AVLT N7 and SCWT-C, longer SCWT-C time, higher levels of phosphorylated tau (P-tau) 396 and synaptophysin, lower CDK5 level and smaller volumes of brain gray and white matters in parts of frontal, parietal, temporal and occipital lobes. This evidence concerns the gene CDK5 and myeloid sarcoma.